Indication for Use: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of ...

Indication for Use: The alfa pump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of ...

bodily fluid or their extract Metabolomic Pertaining to the full complement of all low-molecular-weight molecules present in a tissue, bodily fluid or their extract Independent model Markers that ...

The most common of these include: non-systemic dizziness, balance disorders, nausea and/or vomiting or visual disturbances (6, 11). Table 1. Result of the general cerebrospinal fluid examination. In ...

Following the screening for cell fusion, a total of 12 BP26 mAbs were successfully expressed. Subsequent identification was performed to assess their peptide recognition capabilities and antibody ...

Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...